Molecular Mechanism of Adenovirus Late Protein L4-100K Chaperones the Trimerization of Hexon

Abstract

Adenovirus vectors have been widely used in clinical trials of vaccines and gene therapy, although some deficiencies remain. Chimeric modification of the hexon was expected to improve the potency of preexisting immune evasion and targeting, but in many cases, viral packaging is prevented by the inability of the chimeric hexon to assemble correctly.